Role of lysophospholipid growth factors in the modulation of aqueous humor outflow facility

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 7, 2004, Pages 2263-2271

  Mettu, Priyatham Sai ^a   Deng, Pei Feng ^a   Misra, Uma K ^a   Gawdi, Govind ^a   Epstein, David L ^a   Rao, P Vasantha ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CALCIUM ION; COMPLEMENTARY DNA; G PROTEIN COUPLED RECEPTOR; GENE PRODUCT; GROWTH FACTOR; ISOPROTEIN; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHOLIPID; MYOSIN LIGHT CHAIN; PROTEIN; PROTEIN EDG; PROTEIN EDG 1; PROTEIN EDG 2; PROTEIN EDG 3; RECEPTOR PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AQUEOUS HUMOR OUTFLOW; ARTICLE; CALCIUM MOBILIZATION; CONTROLLED STUDY; CYTOSKELETON; DNA LIBRARY; ENDOTHELIAL DIFFERENTIATION GENE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROFLUOROMETRY; SWINE; TRABECULAR MESHWORK; WESTERN BLOTTING;

ACTINS; ANIMALS; AQUEOUS HUMOR; BLOTTING, WESTERN; CALCIUM; CELL CULTURE TECHNIQUES; ENZYME INHIBITORS; FOCAL ADHESIONS; GENE AMPLIFICATION; HUMANS; LYSOPHOSPHOLIPIDS; MICROSCOPY, FLUORESCENCE; MYOSIN LIGHT CHAINS; PHOSPHORYLATION; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LYSOPHOSPHOLIPID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHO GTP-BINDING PROTEINS; SPECTROMETRY, FLUORESCENCE; SPHINGOSINE; SWINE; TRABECULAR MESHWORK;

EID: 3142688966     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-0960     Document Type: Article

References (47)

1. Lütjenn-Drecoll E. Functional morphology of the trabecular meshwork in primate eyes. Prog Retinal Eye Res. 1998;18:91-119.
2. Johnson M, Erickson K. Mechanism and routes of aqueous humor drainage. In: Albert DM, Lakobiec FA, eds. Principles and Practice of Ophthalmology. Philadelphia: WB Saunders Co.; 2000:2577-2595. Glaucoma; Vol. 4.
3. Johnson M, Erickson K. Mechanism and routes of aqueous humor drainage. In: Albert DM, Lakobiec FA, eds. Principles and Practice of Ophthalmology. Philadelphia: WB Saunders Co.; 2000:2577-2595. Glaucoma; Vol. 4.
4. Tian B, Geiger B, Epstein DL, Kaufman PL. Cytoskeletal involvement in the regulation of aqueous humor outflow. Invest Ophthalmol Vis Sci. 2000;41:619-623.
5. Wiederholt M, Thieme H, Stumff F. The regulation of trabecular meshwork and ciliary muscle contractility. Prog Retinal Eye Res. 2000;19:271-295.
6. Rao PV, Deng PF, Kumar J, Epstein DL. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632. Invest Ophthalmol Vis Sci. 2001;42:1029-1037.
7. Khurana RN, Deng PF, Epstein DL, Rao PV. The role of protein kinase C in modulation of aqueous humor outflow facility. Exp Eye Res. 2003;76:39-47.
8. Epstein DL, Freddo TF, Bassett-Chu S, Chung M, Karageuzian I. Influence of ethacrynic acid on outflow facility in the monkey and calf eye. Invest Ophthalmol Vis Sci. 1987;28:2067-2075.
9. Erickson-Lamy K, Schroeder A, Epstein DL. Ethacrynic acid induces reversible shape and cytoskeletal changes in cultured cells. Invest Ophthalmol Vis Sci. 1992;33:2631-2640.
10. Tian B, Kaufman PL, Volberg T, Gabelt BT, Geiger B. H-7 disrupts the actin cytoskeleton and increases outflow facility. Arch Ophthalmol. 1998;116:633-643.
11. Pang IH, Hellberg PE, Fleenor DL, Jacobson N, Clark AF. Expression of matrix metalloproteinases and their inhibitors in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2003;44:3485-3493.
12. Welge-Lussen U, May CA, Lütjen-Drecoll E. Induction of tissue transglutaminase in the trabecular meshwork by TGF-β1 and TGF-β2. Invest Ophthalmol Vis Sci. 2000;41:2229-2238.
13. Bradley JM, Kelley MJ, Zhu X, Anderssohn AM, Alexander JP, Acott TS. Effects of mechanical stretching on trabecular matrix metalloproteinases. Invest Ophthalmol Vis Sci. 2001;42:1505-1513.
14. Gong H, Ruberti J, Overby D, Johnson M, Freddo TF. A new view of the human trabecular meshwork using quick-freeze, deep-etch electron microscopy. Exp Eye Res. 2002;75:347-358.
15. Epstein DL, Rowlette LL, Roberts BC. Acto-myosin drug effects and aqueous outflow function. Invest Ophthalmol Vis Sci. 1999;40:74-81.
16. Kaufman PL, Gabelt B, Tian B, Liu X. Advances in glaucoma diagnosis and therapy for the next millennium: new drugs for trabecular and uveoscleral outflow. Semin Ophthalmol. 1999;14:130-143.
17. Brubaker RF. Targeting outflow facility in glaucoma management. Surv Ophthalmol. 2003;48:S17-S20.
18. Tripathi RC, Li J, Chan WF, Tripathi BJ. Aqueous humor in glaucomatous eyes contains an increased level of TGF-β2. Exp Eye Res. 1994;59:723-727.
19. Tezel G, Kass MA, Kolker AE, Becker B, Wax MB. Plasma and aqueous humor endothelin levels in primary open-angle glaucoma. J Glaucoma. 1997;6:83-89.
20. Moolenaar WH. Bioactive lysophospholipids and their G protein-coupled receptors. Exp Cell Res. 1999;253:230-238.
21. Hla T, Lee MJ, Ancellin N, Paik JH, Kluk MJ. Lysophospholipid-receptor revelations. Science. 2001;294:1875-1878.
22. Lee MJ, Van Brocklyn JR, Thangada S, et al. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor Edg-1. Science. 1998;279:1552-1555.
23. English D, Brindley DN, Spiegel S, Garcia JGN. Lipid mediators of angiogenesis and the signalling pathways they initiate. Biochim Biophys Acta. 2002;1582:228-239.
24. Siess W. Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate. Biochim Biophys Acta. 2002;1582:204-215.
25. Pagès C, Simon MF, Valet P, Saulnier-Blache JS. Lysophosphatidic acid synthesis and release. Prostaglandins Other Lipid Mediat. 2001;64:1-10.
26. Yatomi Y, Ozaki Y, Ohmori T, Igarashi Y. Sphingosine 1-phosphate: synthesis and release. Prostaglandins Other Lipid Mediat. 2001;64:107-122.
27. Ishizaki T, Uehata M, Tamechika I, et al. Pharmacological properties of Y27632, a specific inhibitor of Rho-associated kinases. Mol Pharmacol. 2000;57:976-983.
28. Toullec D, Pianetti P, Coste H, et al. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem. 1991;266:15771-15781.
29. Saitoh M, Ishikawa T, Matsushima S, Naka M, Hidaka H. Selective inhibition of catalytic activity of smooth muscle myosin light chain kinase. J Biol Chem. 1987;262:7796-7801.
30. Garcia JGN, Davi HW, Patterson CE. Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation. J Cell Physiol. 1995;163:510-522.
31. Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye-binding. Anal Biochem. 1976;72:248-254.
32. Maddala R, Reddy VN, Epstein DL, Rao PV. Growth factor induced activation of Rho and Rac GTPases and actin cytoskeletal reorganization in human lens epithelial cells. Mol Vision. 2003;9:329-336.
33. 2-macroglobulin upstream of the receptor binding domain. Biochemistry. 1997;36:12395-12399.
34. 2M signaling receptor. J Biol Chem. 1994;269:18803-18806.
35. Goetzl EJ, An S. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate. FASEB J. 1998;12:1589-1598.
36. Kluk MJ, Hla T. Signaling of sphingosine-1-phosphate via the S1P/ EDG-family of G-protein-coupled receptors. Biochim Biophys Acta. 2002;1582:72-80.
37. Meacci E, Cencetti F, Donati C, et al. Down-regulation of EDG5/S1P2 during myogenic differentiation results in the specific uncoupling of sphingosine 1-phosphate signalling to phospholipase D. Biochim Biophys Acta. 2003;1633:133-142.
38. Tham CS, Lin FF, Rao TS, Yu N, Webb M. Microglial activation state and lysophospholipid acid receptor expression. Int J Dev Neurosci. 2003;21:431-443.
39. Dolezalova H, Shankar G, Huang MC, Bikle DD, Goetzl EJ. Biochemical regulation of breast cancer cell expression of S1P2 (Edg-5) and S1P3 (Edg-3) G protein-coupled receptors for sphingosine 1-phosphate. J Cell Biochem. 2003;88:732-743.
40. Igarashi J, Erwin PA, Dantas AP, Chen H, Michel T. VEGF induces S1P1 receptors in endothelial cells: implications for cross-talk between sphingolipid and growth factor receptors. Proc Natl Acad Sci USA. 2003;100:10664-10669.
41. Sah VP, Seasholtz TM, Sagi SA, Brown JH. The role of Rho in G protein-coupled receptor signal transduction. Annu Rev Pharmacol Toxicol. 2000;40:459-489.
42. Salomone S, Yoshimura S, Reuter U, et al. S1P3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate. Eur J Pharmacol. 2003;469:125-134.
43. Yun JK, Kester M. Regulatory role of sphingomyelin metabolites in hypoxia-induced vascular smooth muscle cell proliferation. Arch Biochem Biophys. 2002;408:78-86.
44. Sauzeau V, Rolli-Derkinderen M, Lehoux S, Loirand G, Pacaud P. Sildenafil prevents change in RhoA expression induced by chronic hypoxia in rat pulmonary artery. Circ Res. 2003;93:630-637.
45. McMurtry IF, Bauer NR, Fagan KA, Nagaoka T, Gebb SA, Oka M. Hypoxia and Rho/Rho-kinase signaling: lung development versus hypoxic pulmonary hypertension. Adv Exp Med Biol. 2003;543:127-137.
46. Takada Y, Kato C, Kondo S, Korenaga R, Ando J. Cloning of cDNAs encoding G protein-coupled receptor expressed in human endothelial cells exposed to fluid shear stress. Biochem Biophys Res Commun. 1997;240:737-741.
47. Wojciak-Stothard B, Ridley AJ. Shear stress-induced endothelial cell polarization is mediated by Rho and Rac but not Cdc42 or PI 3-kinases. J Cell Biol. 2003;161:429-439.